C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/47 (2006.01) C07K 14/705 (2006.01) C12P 21/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2301684
There is provided according to the present invention, a peptide comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein (MOG), nucleic acid molecules capable of encoding the peptide and the use of such peptide or nucleic acid in medical therapy or screening.
L'invention porte sur un peptide comportant une séquence immunodominante dérivant de la glycoprotéine de l'oligodendrocyte myélinique humain (MOG), sur des molécules d'acide nucléique codant pour ledit peptide, et sur l'emploi dudit peptide ou dudit acide nucléique à des fins de thérapie médicale et de criblage.
Andersson Magnus
Linington Christopher
Olsson Tomas
Wallstrom Erik
Astrazeneca Aktiebolag
Fetherstonhaugh & Co.
LandOfFree
Peptides comprising an immunodominant sequence derived from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides comprising an immunodominant sequence derived from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides comprising an immunodominant sequence derived from... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1660115